In a clinic somewhere off a two-lane highway in rural Pennsylvania, a nurse practitioner logs into a patient record system that still cannot talk to the hospital forty miles away. It is the kind of gap that $50 billion is now meant to close. The US Department of Health and Human Services has begun distributing that sum across all fifty states over five years, with $10 billion released annually to modernise rural facilities, expand telehealth and remote monitoring, and fund the electronic health record systems that let a patient's history follow them out of one building and into another. Pennsylvania alone has been awarded $193 million for the first year of its plan. Each state has been assigned a dedicated federal project officer, and every state must report back to an annual summit where progress is measured against the others.

What makes the American programme notable is not its size but its shape. Half the money is distributed equally across states regardless of need, and half is allocated according to rurality and the strength of each state's proposed interventions, which means underserved geography is treated as the organising principle of the fund rather than an afterthought bolted onto a wider settlement. There is a five-year guarantee on the funds. States know what they are working with and can plan accordingly.

England has nothing that resembles this for its own equivalent geographies. Coastal and rural trusts, the ones that carry the worst vacancy rates and the longest travel times to acute care, are expected to find their digital and infrastructure funding through the same generic channels as everywhere else. Greater Manchester's Integrated Care Board has just published a five-year commissioning plan running to 2031 that promises to shift investment toward prevention and neighbourhood care, with a digital strategy due in January 2027 to make that shift real. Leicester, Leicestershire and Rutland's ICB has published something similar, with its own digital and data strategy expected in September. These are important papers, but they are plans rather than finance settlements, and the funds needed to implement them must still be obtained through national procedures that were not created with rural or coastal inequality as the main consideration. The National Institute for Health and Care Research's FAST programme, one of the few funding routes explicitly aimed at preventative technology in community settings, offers grants of between £50,000 and £100,000. Set against a $10 billion annual American allocation, the disparity in ambition is stark even allowing for the difference in scale between the two health systems.

The deeper problem sits in how NHS capital and revenue funding are kept apart. NHS England's chief executive, Jim Mackey, has acknowledged publicly that the health service pushed for a new accounting classification that would let digital spending move between capital and revenue budgets, and that the change did not materialise. Capital cannot currently be used to cover the ongoing costs of running the technology it pays for, which is precisely the kind of rigidity that a five-year, outcome-tracked fund like the American one is designed to avoid. England has found genuine money for technology this year, including a roughly £10 billion three-year commitment to AI and digital tools and a wider £7.4 billion digital investment plan, but that money still flows through competitive, centrally administered processes that favour trusts with the staff and time to write strong bids. Coastal and rural systems rarely have either in abundance.

The government's stated ambition to shift care from hospital to community depends on the areas furthest from hospitals having the infrastructure to deliver that shift. If the trusts with the thinnest workforce and the weakest connectivity are also the ones least equipped to compete for funding, the policy risks widening the gap it claims to be closing. A dedicated, multi-year fund for rural and coastal NHS systems, structured the way Washington has just structured its own, would cost far less than $50 billion and would still represent a meaningful change in how England treats geographic disadvantage in health policy.